Skip to main content
Article
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab
Cell (2017)
  • Nadeem Riaz, Memorial Sloan Kettering Cancer Center
  • Jonathan J. Havel, Memorial Sloan Kettering Cancer Center
  • Vladimir Makarov, Memorial Sloan Kettering Cancer Center
  • Alexis Desrichard, Memorial Sloan Kettering Cancer Center
  • Walter J. Urba
  • Jennifer S. Sims, Memorial Sloan Kettering Cancer Center
  • F. Stephen Hodi, Harvard University
  • Salvador Martín-Algarra, University of Navarra
  • Rajarsi Mandal, Memorial Sloan Kettering Cancer Center
  • William H. Sharfman, Johns Hopkins University School of Medicine
  • Shailender Bhatia, Fred Hutchinson Cancer Research Center
  • Wen Jen Hwu, University of Texas MD Anderson Cancer Center
  • Thomas F. Gajewski, University of Chicago
  • Craig L. Slingluff, University of Virginia
  • Diego Chowell, Memorial Sloan Kettering Cancer Center
  • Sviatoslav M. Kendall, Memorial Sloan Kettering Cancer Center
  • Han Chang, Bristol-Myers Squibb
  • Rachna Shah, Memorial Sloan Kettering Cancer Center
  • Fengshen Kuo, Memorial Sloan Kettering Cancer Center
  • Luc G.T. Morris, Memorial Sloan Kettering Cancer Center
  • John William Sidhom, Johns Hopkins University School of Medicine
  • Jonathan P. Schneck, Johns Hopkins University School of Medicine
  • Christine E. Horak, Bristol-Myers Squibb
  • Nils Weinhold, Memorial Sloan Kettering Cancer Center
  • Timothy A. Chan, Memorial Sloan Kettering Cancer Center
Publication Date
January 11, 2017
DOI
10.1016/j.cell.2017.09.028
Citation Information
Nadeem Riaz, Jonathan J. Havel, Vladimir Makarov, Alexis Desrichard, et al.. "Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab" Cell Vol. 171 Iss. 4 (2017) p. 934 - 949
Available at: http://works.bepress.com/walter-urba/106/